Target intelligence / Profile preview

Long intergenic non-protein coding RNA 1065 (LINC01065)

Target
LINC01065
Molecular classification
Long intergenic non-coding RNA, Long non-coding RNA, Non-coding RNA
01

Overview

Long intergenic non-protein coding RNA 1065 (LINC01065) is a member of the long intergenic non-coding RNA (lincRNA) family, which are autonomously transcribed RNA molecules longer than 200 nucleotides and positioned between protein-coding genes[1][3]. LincRNAs generally do not encode proteins but may have regulatory roles in gene expression, chromatin remodeling, and the fine-tuning of neighboring gene activities[3][7]. There is currently no published evidence directly linking LINC01065 to a specific biological function, mechanism, or disease association. It is not classified as a canonical therapeutic target such as a receptor, enzyme, or transporter, and there are no known drugs that act on LINC01065. LINC01065 is annotated as a gene in databases such as NCBI Gene (accession: 102723875)[1]. The broader family of lincRNAs has a rapidly evolving functional annotation, but LINC01065 itself lacks specific mechanistic and disease involvement data as of current knowledge[1][3][7]. The molecule is not considered a therapeutic target, nor is there evidence of it being misclassified or misspelled.

Other names
LINC01065long intergenic non-protein coding RNA 1065
02

Biological functions

Unknown (Specific biological functions of LINC01065 have not been characterized or reported in current literature; the general class regulates gene expression and chromatin state)
03

Disease associations

Other (No specific associated disease roles for LINC01065 are reported; however, some LINC RNAs are implicated in cancer, neurodegeneration, and other diseases)

Beyond the preview

Go deeper on Long intergenic non-protein coding RNA 1065 (LINC01065).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Long intergenic non-protein coding RNA 1065 (LINC01065).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call